etoposide has been researched along with Neuroectodermal Tumors, Primitive, Peripheral in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (42.86) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, HS; Kang, HJ; Kim, H; Lee, JW; Park, JD; Park, KD; Shin, HY | 1 |
| Al-Hader, AA; Al-Nasrallah, N; Einhorn, LH; Jain, A | 1 |
| Avansino, J; Gow, KW; Hawkins, DS; Meehan, J; Stephenson, J | 1 |
| Billups, CA; Davidoff, AM; Krasin, MJ; Kun, LE; Merchant, TE; Neel, MD; Rodriguez-Galindo, C | 1 |
| Burger, CW; Ewing, P; Seynaeve, C; Snijders-Keilholz, A | 1 |
| Axtell, RA; Boyett, JM; Breiger, D; Broxson, E; Donahue, B; Finlay, JL; Geyer, JR; Goldwein, JW; Heier, LA; Jennings, M; Johnson, D; Mazewski, C; Miller, DC; Packer, R; Puccetti, D; Radcliffe, J; Shiminski-Maher, T; Sposto, R; Tao, ML | 1 |
| Boven, E; Meijer, OW; Smorenburg, CH; van Groeningen, CJ; Visser, M | 1 |
| Bosl, GJ; Chaganti, RS; Mazumdar, M; Motzer, RJ; Reuter, VE; Rodriguez, E | 1 |
| Herrmann, C; Hiddemann, W; Meyer, T; Schauer, A | 1 |
| Armata, J; Dłuzniewska, A; Grześkowiak-Melanowska, J | 1 |
| Ardouin, P; Bénard, J; Bissery, MC; Boland, I; Bressac-de-Paillerets, B; Gouyette, A; Gyergyay, F; Morizet, J; Terrier-Lacombe, MJ; Vassal, G; Vénuat, AM | 1 |
| Cardenas-Cardos, R; Castellanos-Toledo, A; Gomez-Martínez, R; Lanche-Guevara, T; Leal-Leal, C; Marx-Bracho, A; Rivera-Luna, R; Rueda-Franco, F | 1 |
| Ahrens, S; Dunst, J; Hillmann, A; Hofmann, J; Jürgens, H; Paulussen, M; Rübe, C; Schuck, A; Willich, N | 1 |
| Alloisio, M; Balzarotti, M; Bertuzzi, A; Castagna, L; Compasso, S; Nozza, A; Quagliuolo, V; Santoro, A; Siracusano, L; Soto Parra, H | 1 |
1 review(s) available for etoposide and Neuroectodermal Tumors, Primitive, Peripheral
| Article | Year |
|---|---|
Primitive neuroectodermal tumor of the cervix uteri: a case report -- changing concepts in therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Mesna; Neoadjuvant Therapy; Neuroectodermal Tumors, Primitive, Peripheral; Uterine Cervical Neoplasms; Vincristine | 2005 |
3 trial(s) available for etoposide and Neuroectodermal Tumors, Primitive, Peripheral
| Article | Year |
|---|---|
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Ependymoma; Etoposide; Female; Glioma; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive, Peripheral; Survival Rate; Treatment Outcome; Vincristine | 2005 |
Radiotherapy in Ewing's sarcoma and PNET of the chest wall: results of the trials CESS 81, CESS 86 and EICESS 92.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Neuroectodermal Tumors, Primitive, Peripheral; Retrospective Studies; Sarcoma, Ewing; Thorax; Vincristine | 1998 |
High-dose chemotherapy in poor-prognosis adult small round-cell tumors: clinical and molecular results from a prospective study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Melphalan; Middle Aged; Mitoxantrone; Neuroectodermal Tumors, Primitive, Peripheral; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Rhabdomyosarcoma; Survival Analysis; Thiotepa; Vincristine | 2002 |
10 other study(ies) available for etoposide and Neuroectodermal Tumors, Primitive, Peripheral
| Article | Year |
|---|---|
Irinotecan, vincristine, cisplatin, cyclophosphamide, and etoposide for refractory or relapsed medulloblastoma/PNET in pediatric patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Irinotecan; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive, Peripheral; Radiotherapy; Retrospective Studies; Salvage Therapy; Vincristine; Young Adult | 2013 |
Metastatic malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): results with PNET-based chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Lymph Nodes; Male; Mediastinal Neoplasms; Middle Aged; Neuroectodermal Tumors, Primitive, Peripheral; Pleural Neoplasms; Retroperitoneal Neoplasms; Retrospective Studies; Teratoma; Testicular Neoplasms; Treatment Outcome; Vincristine; Young Adult | 2015 |
Ewing sarcoma/primitive neuroectodermal tumor arising from the adrenal gland in an adolescent.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Neuroectodermal Tumors, Primitive, Peripheral; Radiotherapy; Sarcoma, Ewing; Vincristine | 2011 |
Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neuroectodermal Tumors, Primitive, Peripheral; Prognosis; Radiotherapy Dosage; Retrospective Studies; Sarcoma, Ewing; Treatment Failure; Vincristine | 2004 |
Ewing's sarcoma and primitive neuroectodermal tumour in adults: single-centre experience in The Netherlands.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Netherlands; Neuroectodermal Tumors, Primitive, Peripheral; Retrospective Studies; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2007 |
Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Carcinoma; Chromosome Aberrations; Chromosome Disorders; Cisplatin; Etoposide; Female; Germinoma; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Karyotyping; Lymphoma; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Neuroectodermal Tumors, Primitive, Peripheral; Prospective Studies; Retroperitoneal Neoplasms; Testicular Neoplasms; Treatment Outcome | 1995 |
[Pathology and clinical aspects of peripheral neuroectodermal tumors].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lung Neoplasms; Male; Neuroectodermal Tumors, Primitive, Peripheral; Neurofilament Proteins; Pancoast Syndrome; Vincristine | 1993 |
[Malignant neuroectodermal tumor of the arm in a 15-year-old girl successfully treated with chemo- and radiotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arm; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Neuroectodermal Tumors, Primitive, Peripheral; Radiotherapy Dosage; Vincristine | 1995 |
Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line; Cisplatin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Female; Humans; Irinotecan; Mice; Mice, Nude; Neuroblastoma; Neuroectodermal Tumors, Primitive; Neuroectodermal Tumors, Primitive, Peripheral; Paclitaxel; Thiotepa; Topoisomerase I Inhibitors; Transplantation, Heterologous | 1996 |
Is the ancillary chemotherapy approach of any value in the treatment of infratentorial primitive neuroectodermal tumors with surgery and radiotherapy?
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Infant; Male; Neoplasm Staging; Neuroectodermal Tumors, Primitive, Peripheral; Retrospective Studies; Survival Analysis; Treatment Outcome | 1998 |